Literature DB >> 27340072

Complete Genome Sequence of the First KPC-Type Carbapenemase-Positive Proteus mirabilis Strain from a Bloodstream Infection.

Vincenzo Di Pilato1, Adriana Chiarelli2, Christine J Boinett3, Eleonora Riccobono4, Simon R Harris3, Marco Maria D'Andrea2, Nicholas R Thomson3, Gian Maria Rossolini5, Tommaso Giani6.   

Abstract

Sequencing of the blaKPC-positive strain Proteus mirabilis AOUC-001 was performed using both the MiSeq and PacBio RS II platforms and yielded a single molecule of 4,272,433 bp, representing the complete chromosome. Genome analysis showed the presence of several acquired resistance determinants, including two copies of blaKPC-2 carried on a fragment of a KPC-producing plasmid previously described in Klebsiella pneumoniae.
Copyright © 2016 Di Pilato et al.

Entities:  

Year:  2016        PMID: 27340072      PMCID: PMC4919411          DOI: 10.1128/genomeA.00607-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Proteus mirabilis is one of the leading agents of urinary tract infections and can cause a number of different health care-associated infections, including mainly respiratory tract and skin infections, but also bacteremia (1). Due to a decreased susceptibility to imipenem and an intrinsic resistance to polymyxins and tetracyclines (including tigecycline), the acquisition of β-lactam resistance traits by P. mirabilis might seriously limit treatment options. KPC-type carbapenemases have become the most prevalent acquired carbapenemases in Klebsiella pneumoniae in several areas worldwide (2) and have been sporadically detected also in other Enterobacteriaceae and in Gram-negative nonfermenters (3–6). The acquisition of blaKPC by P. mirabilis represents a rare event, and only a few descriptions have been reported to date (7–9). In this report, we announce the first complete genome sequence of a P. mirabilis strain carrying the blaKPC-2 gene. P. mirabilis AOUC-001 was isolated in 2013 from the blood culture from an inpatient admitted to the Santa Maria Annunziata Hospital (Florence, Italy). A molecular test performed directly on positive blood culture, using the FilmArray platform (Biofire Diagnostics, UT), detected the presence of the blaKPC gene. Bacterial DNA was subjected to whole-genome sequencing using the MiSeq (Illumina, Inc., CA) and the PacBio RS II (Pacific Biosciences, CA, USA) platforms, which generated 4,643,660 and 1,841,288 reads, respectively. Short and long raw reads were processed with the PBcR hybrid assembly pipeline (10), producing 8 scaffolds (largest scaffold, 1.96 Mb; N50, 1.52 Mb; L50, 2; average G+C content, 39.42%). Genome finishing was achieved by manual inspection of the draft assembly, exploiting PacBio long reads for resolution of large repeats, and using short reads to close small gaps (11). The final de novo assembly generated a single molecule of 4,272,433 bp, with a raw coverage of 260×, representing the complete chromosome of AOUC-001. A total of 3,853 coding sequences, 83 tRNAs, 22 rRNAs, and 1 type-IE clustered regularly interspaced short palindromic repeat (CRISPR)-associated (Cas) system were identified by the NCBI Prokaryotic Genome Annotation Pipeline (http://www.ncbi.nlm.nih.gov/genome/annotation_prok). Screening for known virulence determinants (12) revealed the presence of genes associated with adhesion (mannose-resistant/Proteus-like fimbria [MR/P], P. mirabilis fimbria [PMF], and ambient-temperature fimbria [ATF] operons), motility (flgE, fliFL, cheW, and flaD), iron chelation (hmurR2, znuC, and nrp operon), and production of toxic compounds (pta, hpmA, and zapA). The antimicrobial resistome of AOUC-001, investigated using ResFinder (13), included acquired determinants conferring resistance to aminoglycosides (aadA1, aacA4, armA, and aph(3′)-Ic), chloramphenicol (cat and catA1), trimethoprim (dfrA1), and sulfonamides (sul1). Additionally, four different β-lactamase genes (blaCMY-16, blaTEM-1, blaOXA-9, and blaKPC-2) were detected. Interestingly, the blaKPC-2 gene was present in two copies. Further analysis revealed that the two blaKPC-2 copies were embedded in two distinct Tn4401a transposons (14), arranged in a tail-to-tail configuration within the chromosome of AOUC-001. The flanking sequences of these transposons resembled the overall architecture of pKPN101-IT (accession no. JX283456), a KPC-encoding plasmid taken from a K. pneumoniae clinical isolate described in Italy in 2012 (15). Overall, this arrangement suggested a possible integration of a pKPN101-IT-like plasmid within the chromosome of AOUC-001, an event that might have been favored by the endemic presence of KPC-producing K. pneumoniae strains sharing the same setting (16).

Nucleotide sequence accession number.

The complete genome of P. mirabilis AOUC-001 has been deposited at NCBI under the GenBank accession no. CP015347.
  16 in total

1.  Assembling large genomes with single-molecule sequencing and locality-sensitive hashing.

Authors:  Konstantin Berlin; Sergey Koren; Chen-Shan Chin; James P Drake; Jane M Landolin; Adam M Phillippy
Journal:  Nat Biotechnol       Date:  2015-05-25       Impact factor: 54.908

2.  Extensively drug-resistant carbapenemase-producing Enterobacteriaceae: an emerging challenge for clinicians and healthcare systems.

Authors:  G M Rossolini
Journal:  J Intern Med       Date:  2015-02-16       Impact factor: 8.989

3.  Antimicrobial treatment and containment measures for an extremely drug-resistant Klebsiella pneumoniae ST101 isolate carrying pKPN101-IT, a novel fully sequenced bla(KPC-2) plasmid.

Authors:  Ilaria Frasson; Enrico Lavezzo; Elisa Franchin; Stefano Toppo; Luisa Barzon; Antonietta Cavallaro; Sara N Richter; Giorgio Palù
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

4.  Clonal Dissemination of Enterobacter cloacae Harboring blaKPC-3 in the Upper Midwestern United States.

Authors:  Melissa L Hargreaves; Kristin M Shaw; Ginette Dobbins; Paula M Snippes Vagnone; Jane E Harper; Dave Boxrud; Ruth Lynfield; Maliha Aziz; Lance B Price; Kevin A T Silverstein; Jessica L Danzeisen; Bonnie Youmans; Kyle Case; Srinand Sreevatsan; Timothy J Johnson
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

5.  Large Nosocomial Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Traced to Clonal Expansion of an mgrB Deletion Mutant.

Authors:  Tommaso Giani; Fabio Arena; Guendalina Vaggelli; Viola Conte; Adriana Chiarelli; Lucia Henrici De Angelis; Rossella Fornaini; Maddalena Grazzini; Fabrizio Niccolini; Patrizia Pecile; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2015-07-22       Impact factor: 5.948

6.  Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC beta-lactamase in P. mirabilis.

Authors:  R Tibbetts; J G Frye; J Marschall; D Warren; W Dunne
Journal:  J Clin Microbiol       Date:  2008-07-16       Impact factor: 5.948

7.  Detection of KPC in Acinetobacter spp. in Puerto Rico.

Authors:  Iraida E Robledo; Edna E Aquino; María I Santé; Jorge L Santana; Diana M Otero; Carlos F León; Guillermo J Vázquez
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

8.  Identification of acquired antimicrobial resistance genes.

Authors:  Ea Zankari; Henrik Hasman; Salvatore Cosentino; Martin Vestergaard; Simon Rasmussen; Ole Lund; Frank M Aarestrup; Mette Voldby Larsen
Journal:  J Antimicrob Chemother       Date:  2012-07-10       Impact factor: 5.790

9.  Toward almost closed genomes with GapFiller.

Authors:  Marten Boetzer; Walter Pirovano
Journal:  Genome Biol       Date:  2012-06-25       Impact factor: 13.583

10.  Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene.

Authors:  Gaelle Cuzon; Thierry Naas; HaVy Truong; Maria Virginia Villegas; Karin T Wisell; Yehuda Carmeli; Ana C Gales; Shiri Navon Venezia; John P Quinn; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2010-09       Impact factor: 6.883

View more
  6 in total

1.  DNA Packaging and Genomics of the Salmonella 9NA-Like Phages.

Authors:  Chi Zeng; Eddie B Gilcrease; Roger W Hendrix; Yicheng Xie; Michael J Jalfon; Jason J Gill; Sherwood R Casjens
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

2.  Emergence and Evolution of Multidrug-Resistant Klebsiella pneumoniae with both blaKPC and blaCTX-M Integrated in the Chromosome.

Authors:  Weihua Huang; Guiqing Wang; Robert Sebra; Jian Zhuge; Changhong Yin; Maria E Aguero-Rosenfeld; Audrey N Schuetz; Nevenka Dimitrova; John T Fallon
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

3.  Primary and Secondary Bacteremia Caused by Proteus spp.: Epidemiology, Strains Susceptibility and Biofilm Formation.

Authors:  Joanna Kwiecińska-Piróg; Krzysztof Skowron; Eugenia Gospodarek-Komkowska
Journal:  Pol J Microbiol       Date:  2018

Review 4.  Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings.

Authors:  Suprabhat Mukherjee; Nikhilesh Joardar; Subhasree Sengupta; Santi P Sinha Babu
Journal:  J Nutr Biochem       Date:  2018-08-16       Impact factor: 6.048

5.  Draft Genome Sequences of Proteus mirabilis K1609 and K670: A Model Strains for Territoriality Examination.

Authors:  Dawid Gmiter; Grzegorz Czerwonka; Justyna Malgorzata Drewnowska; Izabela Swiecicka; Wieslaw Kaca
Journal:  Curr Microbiol       Date:  2018-11-17       Impact factor: 2.188

Review 6.  Genetics of Acquired Antibiotic Resistance Genes in Proteus spp.

Authors:  Delphine Girlich; Rémy A Bonnin; Laurent Dortet; Thierry Naas
Journal:  Front Microbiol       Date:  2020-02-21       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.